Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)

Clinical trial NCT06099184 · COMPLETED

Trial details

NCT number: NCT06099184
Sponsor: EyePoint Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2024-01-15
Primary completion: 2024-10-24
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.